Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer

ClinicalTrials.gov ID: NCT03237325

Public ClinicalTrials.gov record NCT03237325. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 5:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pivotal, Double-Blind, Randomized, Placebo-Controlled, Multinational Study of SGX942 (Dusquetide) for the Treatment of Oral Mucositis in Patients Being Treated With Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To assess the efficacy of SGX942 compared to placebo in decreasing the duration of severe oral mucositis in patients receiving chemoradiation treatment for the treatment of head and neck cancer

Study identification

NCT ID
NCT03237325
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Soligenix
Industry
Enrollment
266 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 4, 2017 (Actual)
Primary completion
Jun 24, 2020 (Actual)
Completion
Jun 24, 2021 (Actual)
Last update posted
Nov 8, 2022

2017 – 2021

United States locations

U.S. sites
32
U.S. states
22
U.S. cities
32
Facility City State ZIP Site status
Arizona Clinical Research Center Tucson Arizona 85715 —
Loma Linda University Health Loma Linda California 92354 —
Pomona Valley Hospital Medical Center Pomona California 91767 —
Cancer Specialists of North Florida Jacksonville Florida 32256 —
Lakes Research Miami Lakes Florida 33014 —
University Cancer & Blood Athens Georgia 30607 —
Augusta University Augusta Georgia 30912 —
Memorial Health Savannah Georgia 31404 —
University of Illinois Cancer Center Chicago Illinois 60612 —
Carle Cancer Center Urbana Illinois 61801 —
Des Moines Oncology Research Association Des Moines Iowa 50309 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
Ashland Bellefonte Cancer Center Ashland Kentucky 41101 —
Willis Knighton Cancer Center Shreveport Louisiana 71103 —
Karmanos Cancer Institute Detroit Michigan 48201 —
Minnesota Oncology Saint Louis Park Minnesota 55416 —
University of Missouri-Ellis Fischel Cancer Center Columbia Missouri 65203 —
Great Falls Clinic Great Falls Montana 59405 —
CHI Health St. Francis Grand Island Nebraska 68803 —
Comprehensive Cancer Centers of Nevada Henderson Nevada 89052 —
Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
Hackensack Meridian Health Neptune City New Jersey 07753 —
University of Rochester Rochester New York 14642 —
Summa Health Cancer Research Akron Ohio 44304 —
The Christ Hospital Cincinnati Ohio 45219 —
Mercy Clinic Oncology and Hematology Oklahoma City Oklahoma 73120 —
Oklahoma Cancer Specialists Tulsa Oklahoma 74146 —
Charleston Cancer Center Charleston South Carolina 29406 —
Spartanburg Regional-Gibbs Cancer Center Spartanburg South Carolina 29303 —
University of Virginia Charlottesville Virginia 22903 —
Providence Regional Cancer Partnership Everett Washington 98201 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03237325, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 8, 2022 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03237325 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →